Cd19tm1(cre)Cgn/Cd19+ Gt(ROSA)26Sortm2(Cd74/MOG)Awai/Gt(ROSA)26Sor+
involves: 129P2/OlaHsd * C57BL/6
|
abnormal B cell physiology |
J:140751
|
decreased susceptibility to experimental autoimmune encephalomyelitis |
J:140751
|
Cd74em1(IMPC)H/Cd74em1(IMPC)H
C57BL/6N-Cd74em1(IMPC)H/H
|
decreased lymphocyte cell number |
J:211773
|
increased eosinophil cell number |
J:211773
|
increased monocyte cell number |
J:211773
|
increased neutrophil cell number |
J:211773
|
Cd74tm1Doi/Cd74tm1Doi
either: (involves: 129/Sv * B10.BR) or (involves: 129/Sv * C57BL/6)
|
abnormal antigen presentation |
J:4119
|
abnormal level of surface class II molecules |
J:45185
|
decreased CD4-positive, alpha-beta T cell number |
J:4119,
J:45185
|
increased CD8-positive, alpha-beta T cell number |
J:4119
|
Cd74tm1Doi/Cd74tm1Doi
involves: 129S2/SvPas
|
abnormal dendritic cell antigen presentation |
J:151699
|
Cd74tm1Eae/Cd74tm1Eae
B6.129S2-Cd74tm1Eae
|
abnormal lymph node cell ratio |
J:112084
|
arrested B cell differentiation |
J:112084
|
Cd74tm1Eae/Cd74tm1Eae
involves: 129S2/SvPas
|
abnormal level of surface class II molecules |
J:65917
|
decreased B cell proliferation |
J:113050,
J:132865
|
decreased CD4-positive, alpha-beta T cell number |
J:113050
|
decreased cell proliferation |
J:147772
|
decreased IgM level |
J:113050
|
Cd74tm1Eae/Cd74tm1Eae
involves: 129S2/SvPas * C57BL/6
|
increased myocardial infarct size |
J:213776
|
increased susceptibility to myocardial ischemic injury |
J:213776
|
Cd74tm1Liz/Cd74+
involves: 129S/SvEv
|
normal
hematopoietic system phenotype |
J:155870
|
Cd74tm1Liz/Cd74tm1Liz
B6.129S-Cd74tm1Liz
|
abnormal antigen presentation |
J:125654
|
abnormal antigen presentation via MHC class II |
J:28966
|
abnormal level of surface class II molecules |
J:28966
|
abnormal T-helper 1 physiology |
J:125654
|
decreased CD4-positive, alpha-beta T cell number |
J:28966
|
decreased susceptibility to experimental autoimmune encephalomyelitis |
J:125654
|
decreased susceptibility to type IV hypersensitivity reaction |
J:125654
|
decreased T cell proliferation |
J:28966
|
defective assembly of class II molecules |
J:28966
|
Cd74tm1Liz/Cd74tm1Liz
B6.129S-Cd74tm1Liz/J
|
decreased B cell number |
J:194664
|
Cd74tm1Liz/Cd74tm1Liz
involves: 129S/SvEv
|
abnormal positive T cell selection |
J:125548
|
normal
hematopoietic system phenotype |
J:155870
|
Cd74tm1Liz/Cd74tm1Liz
involves: 129S/SvEv * BALB/c * C57BL
|
abnormal antigen presentation via MHC class II |
J:110927
|
abnormal B cell differentiation |
J:110927
|
abnormal dendritic cell antigen presentation |
J:110927
|
abnormal T cell proliferation |
J:110927
|
increased immature B cell number |
J:110927
|
Cd74tm1Liz/Cd74tm1Liz
involves: 129S/SvEv * BALB/cAn
|
abnormal antigen presentation via MHC class II |
J:110927,
J:113714
|
abnormal B cell differentiation |
J:110927
|
abnormal dendritic cell antigen presentation |
J:110927
|
abnormal professional antigen presenting cell physiology |
J:113714
|
decreased CD4-positive, alpha-beta T cell number |
J:110927,
J:113714
|
increased immature B cell number |
J:110927
|
Cd74tm1Liz/Cd74tm1Liz
involves: 129S/SvEv * C57BL * C57BL/10 * C57BR
|
abnormal antigen presentation via MHC class II |
J:110927
|
abnormal B cell differentiation |
J:110927
|
abnormal dendritic cell antigen presentation |
J:110927
|
abnormal T cell proliferation |
J:110927
|
increased immature B cell number |
J:110927
|
Cd74tm1Liz/Cd74tm1Liz
involves: 129S/SvEv * C57BL/6
|
abnormal antigen presentation via MHC class II |
J:111565
|
Cd74tm1Liz/Cd74tm1Liz
involves: 129S/SvEv * C57BL/6J
|
abnormal antigen presentation |
J:72243
|
abnormal antigen presentation via MHC class II |
J:65918
|
abnormal level of surface class II molecules |
J:65918
|
cachexia |
J:65918
|
decreased body size |
J:65918
|
decreased CD4-positive, alpha-beta T cell number |
J:65918
|
decreased interferon-gamma secretion |
J:72243
|
decreased susceptibility to experimental autoimmune encephalomyelitis |
J:72243
|
decreased T cell proliferation |
J:72243
|
defective assembly of class II molecules |
J:65918
|
Cd74tm2Liz/Cd74tm1Liz
involves: 129S/SvEv * C57BL/6
|
abnormal antigen presentation via MHC class II |
J:28966
|
normal
immune system phenotype |
J:28966
|
increased T cell proliferation |
J:28966
|
Cd74tm2Liz/Cd74tm2Liz
involves: 129S/SvEv * C57BL/6
|
decreased interleukin-2 secretion |
J:72243
|
increased susceptibility to experimental autoimmune encephalomyelitis |
J:72243
|